On March 13th, Aidea Pharma received the "GMP Certificate" issued by the Zanzibar Food and Drug Authority. This is the company's first overseas GMP certificate, which is of great significance, marking that the company's relevant production sites fully meet the production requirements for oral solid dosage products set by the Zanzibar Food and Drug Authority, creating favorable conditions for the company's innovative anti-HIV drug, Enomitab, and other products to enter the Zanzibar market
